Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa

Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB pat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of acquired immune deficiency syndromes (1999) Vol. 62; no. 4; p. 436
Main Authors: Brust, James C M, Shah, N Sarita, van der Merwe, Theo L, Bamber, Sheila, Ning, Yuming, Heo, Moonseong, Moll, Anthony P, Loveday, Marian, Lalloo, Umesh G, Friedland, Gerald H, Gandhi, Neel R
Format: Journal Article
Language:English
Published: United States 01.04.2013
Subjects:
Antitubercular Agents - adverse effects
Antitubercular Agents - therapeutic use
HIV Infections - complications
HIV Infections - drug therapy
Home Care Services
Humans
South Africa
Tuberculosis, Multidrug-Resistant - complications
Tuberculosis, Multidrug-Resistant - drug therapy
South Africa
ISSN:1944-7884, 1944-7884
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB patients, 74 (81%) were HIV-positive and receiving antiretroviral therapy. AEs were common, but most were mild and did not require therapy modification. The most common severe AEs were hypothyroidism (36%) and psychosis (5%). Patients receiving concurrent antiretroviral therapy did not experience AEs more frequently than those on MDR-TB therapy alone. Concurrent treatment for MDR-TB/HIV can be safely administered in a home-based care setting.
AbstractList Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB patients, 74 (81%) were HIV-positive and receiving antiretroviral therapy. AEs were common, but most were mild and did not require therapy modification. The most common severe AEs were hypothyroidism (36%) and psychosis (5%). Patients receiving concurrent antiretroviral therapy did not experience AEs more frequently than those on MDR-TB therapy alone. Concurrent treatment for MDR-TB/HIV can be safely administered in a home-based care setting.Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB patients, 74 (81%) were HIV-positive and receiving antiretroviral therapy. AEs were common, but most were mild and did not require therapy modification. The most common severe AEs were hypothyroidism (36%) and psychosis (5%). Patients receiving concurrent antiretroviral therapy did not experience AEs more frequently than those on MDR-TB therapy alone. Concurrent treatment for MDR-TB/HIV can be safely administered in a home-based care setting.
Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB patients, 74 (81%) were HIV-positive and receiving antiretroviral therapy. AEs were common, but most were mild and did not require therapy modification. The most common severe AEs were hypothyroidism (36%) and psychosis (5%). Patients receiving concurrent antiretroviral therapy did not experience AEs more frequently than those on MDR-TB therapy alone. Concurrent treatment for MDR-TB/HIV can be safely administered in a home-based care setting.
Author Loveday, Marian
Heo, Moonseong
Lalloo, Umesh G
Moll, Anthony P
van der Merwe, Theo L
Ning, Yuming
Gandhi, Neel R
Friedland, Gerald H
Brust, James C M
Shah, N Sarita
Bamber, Sheila
Author_xml – sequence: 1
  givenname: James C M
  surname: Brust
  fullname: Brust, James C M
  organization: Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY †Philanjalo and Church of Scotland Hospital, Tugela Ferry, South Africa ‡Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa §Department of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY ‖Health Systems Research Unit, Medical Research Council, Cape Town, South Africa ¶Department of Medicine, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; Departments of #Medicine and Epidemiology, Yale University School of Medicine, New Haven, CT ††Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA
– sequence: 2
  givenname: N Sarita
  surname: Shah
  fullname: Shah, N Sarita
– sequence: 3
  givenname: Theo L
  surname: van der Merwe
  fullname: van der Merwe, Theo L
– sequence: 4
  givenname: Sheila
  surname: Bamber
  fullname: Bamber, Sheila
– sequence: 5
  givenname: Yuming
  surname: Ning
  fullname: Ning, Yuming
– sequence: 6
  givenname: Moonseong
  surname: Heo
  fullname: Heo, Moonseong
– sequence: 7
  givenname: Anthony P
  surname: Moll
  fullname: Moll, Anthony P
– sequence: 8
  givenname: Marian
  surname: Loveday
  fullname: Loveday, Marian
– sequence: 9
  givenname: Umesh G
  surname: Lalloo
  fullname: Lalloo, Umesh G
– sequence: 10
  givenname: Gerald H
  surname: Friedland
  fullname: Friedland, Gerald H
– sequence: 11
  givenname: Neel R
  surname: Gandhi
  fullname: Gandhi, Neel R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23254152$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtOwzAQRS1URGnhDxDykgUptuM8vAzl0YoCAgoLNpFjT2hQHsV2ivh7jCgSm5krzZmrOzNCg7ZrAaEjSiaUiOTsIZtPSEFoCCFNWUqTCPQO2qeC8yBJUz74p4doZO07ITTmXOyhIQtZxGnE9lGb6Q0YCxg20DqLqxbL1lcHb0Y60HjVNRAU0nrpDEjXeAyvTefHDS47g28vHoPlud_SeDZ_-TG4-ZSvfd0Hd9LJ-hQ_db1b4aw0lZIHaLeUtYXDbR-j56vL5XQWLO6v59NsEag4FC4owlSrlIuS8VIRIiGWKhKKRv5GRjUpwjIEoWKqVVIUisRcJwXXUqaEiyiN2Rid_Pr6pB89WJc3lVVQ17KFrrc55ZyHglAeefR4i_ZFAzpfm6qR5iv_-xH7BlPgbAk
CitedBy_id crossref_primary_10_1093_jac_dkx107
crossref_primary_10_1371_journal_pone_0248017
crossref_primary_10_21292_2075_1230_2022_100_4_46_51
crossref_primary_10_1016_S2213_2600_14_70031_1
crossref_primary_10_22625_2072_6732_2025_17_1_26_35
crossref_primary_10_1016_j_jinf_2018_07_007
crossref_primary_10_1183_13993003_00803_2016
crossref_primary_10_1186_s12879_016_1933_0
crossref_primary_10_1093_cid_cix1125
crossref_primary_10_1097_QAI_0000000000002190
crossref_primary_10_1186_s12955_019_1155_4
crossref_primary_10_1080_20523211_2024_2332878
crossref_primary_10_2147_PPA_S333111
crossref_primary_10_1183_23120541_00537_2020
crossref_primary_10_1080_17441692_2014_934266
crossref_primary_10_1136_archdischild_2015_310186
crossref_primary_10_1371_journal_pone_0078313
crossref_primary_10_21292_2075_1230_2022_100_11_56_65
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/QAI.0b013e31828175ed
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1944-7884
ExternalDocumentID 23254152
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations South Africa
GeographicLocations_xml – name: South Africa
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: K23 AI083088
– fundername: PEPFAR
– fundername: NIAID NIH HHS
  grantid: R01 AI089349
– fundername: NIAID NIH HHS
  grantid: P30 AI051519
– fundername: NIAID NIH HHS
  grantid: R01 AI087465
GroupedDBID ---
.-D
.XZ
.Z2
01R
1J1
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
77Y
7O~
8L-
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AARTV
AASOK
AAXQO
ABBUW
ABDIG
ABIVO
ABPXF
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACPRK
ACWDW
ACWRI
ACXNZ
ACZKN
ADGGA
ADHPY
AE3
AE6
AEETU
AFDTB
AFEXH
AFNMH
AFRAH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
BKOMP
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DUNZO
E.X
EBS
ECM
EIF
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRJ
FRP
FW0
H0~
HZ~
IKREB
IKYAY
IN~
JK3
JK8
K8S
KD2
KMI
L-C
NPM
N~7
N~B
O9-
OAG
OAH
ODMTH
OHH
OHYEH
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OWV
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RLZ
RXW
S4R
S4S
TAE
TEORI
V2I
VVN
W2D
W3M
WOQ
WOW
X3V
X3W
XYM
YOC
ZZMQN
7X8
ADKSD
ID FETCH-LOGICAL-c639t-b38dc849f24fc00ae6ac59c155ed21d0b3f3e9c61dc7bbc064d7b4daa80495862
IEDL.DBID 7X8
ISICitedReferencesCount 24
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000319037700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1944-7884
IngestDate Mon Sep 08 11:47:43 EDT 2025
Mon Jul 21 06:03:31 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c639t-b38dc849f24fc00ae6ac59c155ed21d0b3f3e9c61dc7bbc064d7b4daa80495862
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3641171
PMID 23254152
PQID 1444390145
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1444390145
pubmed_primary_23254152
PublicationCentury 2000
PublicationDate 2013-04-01
PublicationDateYYYYMMDD 2013-04-01
PublicationDate_xml – month: 04
  year: 2013
  text: 2013-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of acquired immune deficiency syndromes (1999)
PublicationTitleAlternate J Acquir Immune Defic Syndr
PublicationYear 2013
References 16468160 - Int J Tuberc Lung Dis. 2005 Dec;9(12):1373-7
20132617 - Int J Tuberc Lung Dis. 2010 Mar;14(3):275-81
22668560 - Int J Tuberc Lung Dis. 2012 Aug;16(8):998-1004
15581210 - Int J Tuberc Lung Dis. 2004 Nov;8(11):1382-4
22236862 - Int J Tuberc Lung Dis. 2012 Jan;16(1):141
19833824 - Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6
12519922 - N Engl J Med. 2003 Jan 9;348(2):119-28
19779624 - PLoS One. 2009;4(9):e7186
20202299 - Int J Tuberc Lung Dis. 2010 Apr;14(4):420-6
13447774 - Dis Chest. 1957 Aug;32(2):172-82
22792406 - PLoS One. 2012;7(7):e40781
21828024 - Eur Respir J. 2011 Sep;38(3):516-28
15182146 - Int J Tuberc Lung Dis. 2004 Jun;8(6):749-59
18221534 - BMC Infect Dis. 2008;8:10
18034952 - Int J Tuberc Lung Dis. 2007 Dec;11(12):1314-20
22326109 - Int J Tuberc Lung Dis. 2012 Apr;16(4):468-72
20019591 - Am J Ther. 2011 Mar-Apr;18(2):e29-34
11467371 - Int J Tuberc Lung Dis. 2001 Jul;5(7):648-55
21253585 - PLoS One. 2011;6(1):e15841
References_xml – reference: 16468160 - Int J Tuberc Lung Dis. 2005 Dec;9(12):1373-7
– reference: 19779624 - PLoS One. 2009;4(9):e7186
– reference: 21828024 - Eur Respir J. 2011 Sep;38(3):516-28
– reference: 21253585 - PLoS One. 2011;6(1):e15841
– reference: 20132617 - Int J Tuberc Lung Dis. 2010 Mar;14(3):275-81
– reference: 18034952 - Int J Tuberc Lung Dis. 2007 Dec;11(12):1314-20
– reference: 12519922 - N Engl J Med. 2003 Jan 9;348(2):119-28
– reference: 20019591 - Am J Ther. 2011 Mar-Apr;18(2):e29-34
– reference: 22668560 - Int J Tuberc Lung Dis. 2012 Aug;16(8):998-1004
– reference: 19833824 - Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6
– reference: 13447774 - Dis Chest. 1957 Aug;32(2):172-82
– reference: 15182146 - Int J Tuberc Lung Dis. 2004 Jun;8(6):749-59
– reference: 22792406 - PLoS One. 2012;7(7):e40781
– reference: 20202299 - Int J Tuberc Lung Dis. 2010 Apr;14(4):420-6
– reference: 18221534 - BMC Infect Dis. 2008;8:10
– reference: 11467371 - Int J Tuberc Lung Dis. 2001 Jul;5(7):648-55
– reference: 22236862 - Int J Tuberc Lung Dis. 2012 Jan;16(1):141
– reference: 22326109 - Int J Tuberc Lung Dis. 2012 Apr;16(4):468-72
– reference: 15581210 - Int J Tuberc Lung Dis. 2004 Nov;8(11):1382-4
SSID ssj0016449
Score 2.2350152
Snippet Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 436
SubjectTerms Antitubercular Agents - adverse effects
Antitubercular Agents - therapeutic use
HIV Infections - complications
HIV Infections - drug therapy
Home Care Services
Humans
South Africa
Tuberculosis, Multidrug-Resistant - complications
Tuberculosis, Multidrug-Resistant - drug therapy
Title Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa
URI https://www.ncbi.nlm.nih.gov/pubmed/23254152
https://www.proquest.com/docview/1444390145
Volume 62
WOSCitedRecordID wos000319037700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvDo0jTZPPYk9VFapKFKleIlbPaBBU2qafXvO7tJ25MgeMltQ9idzHwz8-18CF24KZiBUpRIrRWhnvZIBL6YCEi3mOs6TDFuxSbCOI6GQ9avCm5FRauc-UTrqGUuTI28AcCfmvyc-lfjD2JUo0x3tZLQWEY1D6CMsepwuOgiQKxntqtMqWHN0dnVORY2HlrdRQ3QjSCIKvk7yLTBpr3538_cQhsVzMSt0i620ZLKdtBar2qk76LMCjEXCtsBTgUeZZhneD47QuLX_F0RE-IknnPRcUXmwgB0ce_2kQyuYZXEne6zecH9N3-Zvk1JbCpCl9iK8-FSh2gPPbXvBjcdUkkvEAGQZUJSL5Iioky7VAvH4SrgwmcCwIeSblM6KRyqYiJoShGmqQBcI8OUSs4jyDh8yJL20UqWZ-oQ4QCCo3QD5ciAUWYuOwhfcp1SHTCV6mYdnc92MgHTNv0Knql8WiSLvayjg_I4knE5gyMBIOgb7HH0h9XHaN21IhaGb3OCahp-bHWKVsXXZFR8nlmbgWfc7_0AO03Lig
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adverse+events+in+an+integrated+home-based+treatment+program+for+MDR-TB+and+HIV+in+KwaZulu-Natal%2C+South+Africa&rft.jtitle=Journal+of+acquired+immune+deficiency+syndromes+%281999%29&rft.au=Brust%2C+James+C+M&rft.au=Shah%2C+N+Sarita&rft.au=van+der+Merwe%2C+Theo+L&rft.au=Bamber%2C+Sheila&rft.date=2013-04-01&rft.eissn=1944-7884&rft.volume=62&rft.issue=4&rft.spage=436&rft_id=info:doi/10.1097%2FQAI.0b013e31828175ed&rft_id=info%3Apmid%2F23254152&rft_id=info%3Apmid%2F23254152&rft.externalDocID=23254152
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1944-7884&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1944-7884&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1944-7884&client=summon